3800 Reservoir Rd Nw, 
Washington, DC 

Overview

Amal Abu is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Abu has been practicing medicine for over 34 years. Her top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in DC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

3800 Reservoir Rd Nw, Washington, DC 20007

Additional Areas of Focus

Dr. Abu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Neuroblastoma Biology Studies
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
View 6 Less Clinical Trials
Similar Doctors
Expertise in
19
conditions
Pediatric Hematology Oncology
Expertise in
19
conditions
Pediatric Hematology Oncology
10 Center Drive, National Institutes Of Health Clinical Center, 
Bethesda, MD 
 (6.5 miles away)
Languages Spoken:
English

Sharon Savage is a Pediatric Hematologist Oncology provider in Bethesda, Maryland. Dr. Savage is highly rated in 19 conditions, according to our data. Her top areas of expertise are Dyskeratosis Congenita, Aplastic Anemia, Aase Syndrome, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).

Expertise in
13
conditions
Pediatric Hematology Oncology
Expertise in
13
conditions
Pediatric Hematology Oncology
9609 Medical Center Dr, Room 6e452, 
Rockville, MD 
 (14.8 miles away)
Languages Spoken:
English

Blanche Alter is a Pediatric Hematologist Oncology provider in Rockville, Maryland. Dr. Alter is highly rated in 13 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Dyskeratosis Congenita, Aplastic Anemia, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).

Expertise in
6
conditions
Pediatric Hematology Oncology
Expertise in
6
conditions
Pediatric Hematology Oncology
111 Michigan Ave Nw, 
Washington, DC 
 (3.4 miles away)
Languages Spoken:
English

Caterina Minniti is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Minniti is highly rated in 6 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abu's expertise for a condition
ConditionClose
          Want to save this doctor for later?
          Sign Up
          Is this your doctor?
          Find A Second Opinion
          Not sure about your diagnosis?
          Check Your Symptoms
           
           
           
           
          Learn about our expert tiers
          Learn More
          Are you the provider on this profile?
          Claim Profile